ProCE Banner Activity

Urothelial Cancer: Current First-line Therapy Guidelines and Recommendations

Slideset Download
Download these slides from a live Webinar to gain expert insight on the optimal treatment options for first-line therapy for patients with metastatic urothelial cancer, including the latest evidence from ASCO GU 2021.

Released: February 22, 2021

Expiration: February 21, 2022

No longer available for credit.

Share

Faculty

Matthew Galsky

Matthew Galsky, MD

Professor of Medicine
Director of Genitourinary Medical Oncology
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer and EMD Serono

Faculty Disclosure

Primary Author

Matthew Galsky, MD

Professor of Medicine
Director of Genitourinary Medical Oncology
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York